52 Participants Needed

Skin Substitute for Burns

Recruiting at 7 trial locations
VJ
LG
Overseen ByLucie Germain, PhD
Age: Any Age
Sex: Any
Trial Phase: Phase 1 & 2
Sponsor: CHU de Quebec-Universite Laval
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new treatment called Self Assembled Skin Substitute (SASS) as a permanent skin replacement for severe burn wounds. Researchers aim to determine if SASS is safe and effective for individuals with deep burns who lack enough healthy skin for traditional grafts. It suits those with burns covering over 50% of their body and insufficient donor skin. Participants will receive both SASS and another type of skin graft, called Split-thickness Autograft, to compare results. As a Phase 1, Phase 2 trial, this research focuses on understanding how SASS works in people and measuring its effectiveness in an initial group, offering participants a chance to be among the first to benefit from this innovative treatment.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that the Self Assembled Skin Substitute (SASS) has undergone testing in clinical trials for individuals with severe burns. In these studies, SASS served as a permanent skin cover for deep wounds. A report on 14 patients with serious burns showed positive results with SASS, indicating it can effectively cover and heal burn areas.

So far, the data suggests that SASS is generally well-tolerated. No major safety concerns have been reported, suggesting it might be safe for most people. It's important to remember that this treatment is still under study, so researchers continue to learn about its safety. However, the current findings are promising.12345

Why do researchers think this study treatment might be promising?

Unlike the standard of care for burn treatment, which typically involves split-thickness autografts, the Self Assembled Skin Substitute (SASS) offers a unique approach by using a patient's own cells to create a skin substitute. This method is exciting because SASS aims to provide a more natural skin repair, potentially reducing the risk of rejection and improving cosmetic outcomes. Additionally, as SASS is cultivated and assembled into a skin substitute, it might offer a more tailored healing process, promoting better integration with the patient's own skin and potentially enhancing long-term recovery.

What evidence suggests that Self Assembled Skin Substitute (SASS) is effective for treating full-thickness burn wounds?

Research has shown that Self Assembled Skin Substitutes (SASS), which participants in this trial will receive, hold promise for treating severe burns. One study demonstrated that SASS provided lasting skin coverage for patients with serious burns, particularly when donor skin was scarce. A report on 14 patients with large burns showed that SASS effectively covered their wounds. This treatment involves placing SASS onto burn wounds, which has successfully aided healing. It has been used in patients with burns covering more than half of their body, suggesting effectiveness for major burn injuries.12367

Who Is on the Research Team?

VJ

Veronique J Moulin, PhD

Principal Investigator

CHU de Quebec

Are You a Good Fit for This Trial?

This trial is for individuals with deep second-degree or third-degree burns covering over 50% of their body, where traditional skin graft donor sites are limited. It's not suitable for those needing grafts only on sensitive areas like the face or hands, people with uncontrolled diabetes, coagulation disorders, connective tissue diseases, immunodeficiency before being burned, or hypersensitivity to bovine proteins.

Inclusion Criteria

I have severe burns covering more than half of my body.
Consent obtained by the participant or by the appropriate representative in case of inapt prospective participants or minors
I have few areas on my body suitable for tissue donation for grafts.

Exclusion Criteria

I had uncontrolled diabetes before getting a burn injury.
I need skin grafting on my face, hands, feet, ears, or genital area only.
I have a connective tissue disease.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment Phase A

All patients receive both Self Assembled Skin Substitute (SASS) and Split-thickness autograft

< 1 month

Treatment Phase B

All patients receive Self Assembled Skin Substitute (SASS)

< 1 month

Follow-up

Participants are monitored for safety and effectiveness after treatment, including adverse events and quality of life assessments

36 months

What Are the Treatments Tested in This Trial?

Interventions

  • Self Assembled Skin Substitute (SASS)
  • Split-thickness Autograft
Trial Overview The trial is testing a Self Assembled Skin Substitute (SASS) as a permanent solution for severe burn wounds when there's not enough healthy skin available for grafts. The goal is to see if SASS can safely and effectively replace damaged skin.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Treatment (SASS)Experimental Treatment1 Intervention

Self Assembled Skin Substitute (SASS) is already approved in Canada for the following indications:

🇨🇦
Approved in Canada as SASS for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

CHU de Quebec-Universite Laval

Lead Sponsor

Trials
177
Recruited
110,000+

Published Research Related to This Trial

The use of Novosorb™ Biodegradable Temporizing Matrix as a temporary dermal replacement for 3 months helped stabilize an 86% surface area flame burn in a pediatric patient, showcasing its effectiveness in managing severe burn injuries.
The introduction of Self-Assembled Skin Substitute (SASS) as a permanent skin replacement allowed for successful coverage of the burns, contributing to the child's unprecedented survival after a life-threatening injury.
Surviving an Extensive Burn Injury Using Advanced Skin Replacement Technologies.Kelly, C., Wallace, D., Moulin, V., et al.[2022]
The Self-Assembled Skin Substitute (SASS) can now be produced in 31 days instead of the previous 45 days, optimizing the manufacturing process for skin substitutes using the patient's own cells.
Both the new production methods resulted in skin substitutes that maintained similar quality and performance as the original method, which is crucial for effective treatment in severely burned patients.
Improved Methods to Produce Tissue-Engineered Skin Substitutes Suitable for the Permanent Closure of Full-Thickness Skin Injuries.Larouche, D., Cantin-Warren, L., Desgagné, M., et al.[2020]
The self-assembled skin substitute (SASS) showed promise as a biological dressing for treating hard-to-heal chronic venous and mixed ulcers, with 14 ulcers treated in 5 patients, requiring an average of 6.7 applications for healing.
While two ulcers experienced minor infections and some recurred, the overall results indicate that SASS can be an effective adjunct to standard compression therapy for patients with ulcers unresponsive to conventional treatments.
Prospective study on the treatment of lower-extremity chronic venous and mixed ulcers using tissue-engineered skin substitute made by the self-assembly approach.Boa, O., Cloutier, CB., Genest, H., et al.[2013]

Citations

The Self-Assembled Skin Substitute HistorySince the 1980s, as intensive care treatment improved and skin substitutes became more readily available, survival after burn injuries significantly increased.
autologous bilayered self-assembled skin substitutesThe aim of the study was to assess the clinical outcome of the SASSs as a permanent coverage for full-thickness burn wounds. Patients were recruited through the ...
3.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/30209799/
a case series of 14 severely burned patients indicating ...The aim of the study was to assess the clinical outcome of the SASSs as a permanent coverage for full-thickness burn wounds. Patients were ...
First-in-human application of the self-assembled skin ...SASSs were used to treat patients suffering from severe burn wounds over more than 50% of their total body surface area. The SASSs were grafted after surgical ...
Safety and Efficacy Study of Autologous Engineered Skin ...This study is designed to evaluate the safety and efficacy of autologous engineered skin substitute (ESS-W) compared to conventional split-thickness AG.
SASS 2 : Self Assembled Skin Substitute for the Autologous ...This clinical trial is designed to assess the safety, effectiveness and benefits of Self Assembled Skin Substitute SASS grafts as a permanent skin ...
Skin Substitute for BurnsThe Self-Assembled Skin Substitute (SASS) has been used in clinical trials for treating severe burns, showing a high success rate in grafting and long-term skin ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security